Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Edito Fabrizio
Observed names:
E Fabrizio,
E. Fabrizio,
Fabrizio Edito
Observed institutions:
University of Messina,
Istituto Superiore di Sanità,
Policlinico Umberto I,
Ludwig-Maximilians-Universität München,
Sapienza University of Rome
OpenAlex ID:
A5108113895
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease
2005
·
Alessio Di Fonzo
, Christan F Rohé
, et al.
·
The Lancet
·
528
A susceptibility locus for Parkinson's disease maps to chromosome 2p13
1998
·
Thomas Gasser
, Bertram Müller-Myhsok
, et al.
·
Nature Genetics
·
455
Buspirone in Levodopa-Induced Dyskinesias
1994
·
Vincenzo Bonifati
, Edito Fabrizio
, et al.
·
Clinical Neuropharmacology
·
181
Frontal lobe dysfunction in essential tremor
2001
·
Marina Gasparini
, Vincenzo Bonifati
, et al.
·
Journal of Neurology
·
179
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study
2018
·
Marialuisa Quadri
, Wim Mandemakers
, et al.
·
The Lancet Neurology
·
140
Familial Parkinson’s Disease: A Clinical Genetic Analysis
1995
·
Vincenzo Bonifati
, Edito Fabrizio
, et al.
·
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
·
104
PDF
The α‐synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: A study of 230 European cases
1998
·
Jenny Vaughan
, Alexandra Durr
, et al.
·
Annals of Neurology
·
80
Mirtazapine in l-Dopa-Induced Dyskinesias
2003
·
Giuseppe Meco
, Edito Fabrizio
, et al.
·
Clinical Neuropharmacology
·
54
PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability
2022
·
Christina Fevga
, Christelle Tesson
, et al.
·
Brain
·
34
PDF
Aripiprazole in l-dopa-induced dyskinesias: a one-year open-label pilot study
2009
·
Giuseppe Meco
, Paola Stirpe
, et al.
·
Journal of Neural Transmission
·
34
Levetiracetam in Tardive Dyskinesia
2006
·
Giuseppe Meco
, Edito Fabrizio
, et al.
·
Clinical Neuropharmacology
·
33
GIGYF2 mutations are not a frequent cause of familial Parkinson's disease
2009
·
Alessio Di Fonzo
, Edito Fabrizio
, et al.
·
Parkinsonism & Related Disorders
·
23
High prevalence of extrapyramidal signs and symptoms in a group of Italian dental technicians
2007
·
Edito Fabrizio
, Nicola Vanacore
, et al.
·
BMC Neurology
·
22
PDF
Worsening of parkinsonism with fluvoxamine—two cases
1994
·
Giuseppe Meco
, Vincenzo Bonifati
, et al.
·
Human Psychopharmacology Clinical and Experimental
·
20
Mutations in TMEM230 are not a common cause of Parkinson's disease
2017
·
Marialuisa Quadri
, Guido J. Breedveld
, et al.
·
Movement Disorders
·
16
Mortality Rates for Parkinson's Disease and Parkinsonism in Italy (1969–1987)
1992
·
Nicola Vanacore
, Vincenzo Bonifati
, et al.
·
Neuroepidemiology
·
16
Levetiracetam in L-Dopa-Induced Dyskinesia
2005
·
G Meco
, E Fabrizio
, et al.
·
Clinical Neuropharmacology
·
12
2.279 Aripiprazole in L-Dopa induced dyskinesias (LID): One year open study
2007
·
G. Meco
, E. Fabrizio
, et al.
·
Parkinsonism & Related Disorders
·
1
Studio clinico ed epidemiologico di una comunità esposta a campo magnetico a 50 hz
2015
·
Introduzione
, Nicola Vanacore
, et al.
Sindrome demielinizzante multifocale centrale e periferica con epilessia. Presentazione di un caso
1999
·
Edito Fabrizio
, S Fabri
, et al.
·
Rivista di Neurobiologia
Acute administration of levodopa + carbidopa before and after four months of treatment with Tolcapone in advanced Parkinson's disease
1996
·
G. Meco
, P. Zuchegna
, et al.
·
European Neuropsychopharmacology
Show more works
View as search
Works count:
22
Citation count:
2,072
H-index:
16
I10-index:
18
Year
Topic
Type